Shelly C, Petruzzelli L, Herrera R
Department of Cell Biology, Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
Leukemia. 1998 Dec;12(12):1951-61. doi: 10.1038/sj.leu.2401221.
Erythroid and megakaryocyte lineages are closely linked and may share a common bipotent progenitor. However, the mechanisms associated with cell lineage commitment are not fully understood. The K562 erythroleukemia cell line serves as a model to study the biochemical changes associated with erythroid and megakaryocyte (E/M) differentiation. We have previously established that PMA-induced megakaryocyte differentiation of K562 cells requires the activity of the MEK/MAPK pathway (Herrera et al Exp Cell Res 1998; 238: 407-414). Here, we show that the PMA-induced phenotypic changes of K562 cells such as polylobulation of the nucleus and Pyk2 expression are independent of MAPK activation. In addition, we also demonstrate that inhibition of the basal activity of the extracellular regulated kinase (ERK/MAPK) pathway enhances the erythroid phenotype of these cells. These results suggest that the MAPK pathway regulates the E/M lineage commitment of K562 cells.
红系和巨核细胞系密切相关,可能共享一个共同的双能祖细胞。然而,与细胞谱系定向相关的机制尚未完全了解。K562红白血病细胞系作为研究与红系和巨核细胞(E/M)分化相关的生化变化的模型。我们之前已经确定,PMA诱导的K562细胞巨核细胞分化需要MEK/MAPK途径的活性(Herrera等人,《实验细胞研究》1998年;238:407 - 414)。在此,我们表明PMA诱导的K562细胞表型变化,如细胞核分叶和Pyk2表达,与MAPK激活无关。此外,我们还证明抑制细胞外调节激酶(ERK/MAPK)途径的基础活性可增强这些细胞的红系表型。这些结果表明MAPK途径调节K562细胞的E/M谱系定向。